Northern Trust Corp Increases Stock Position in NeueHealth, Inc. (NYSE:NEUE)

Northern Trust Corp boosted its holdings in NeueHealth, Inc. (NYSE:NEUEFree Report) by 66.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 32,644 shares of the company’s stock after acquiring an additional 13,074 shares during the quarter. Northern Trust Corp owned 0.39% of NeueHealth worth $242,000 at the end of the most recent quarter.

Separately, Virtu Financial LLC bought a new position in NeueHealth during the fourth quarter valued at approximately $76,000. Institutional investors own 63.88% of the company’s stock.

NeueHealth Price Performance

Shares of NEUE opened at $6.84 on Tuesday. The firm has a market capitalization of $61.02 million, a P/E ratio of -0.13 and a beta of 0.53. NeueHealth, Inc. has a one year low of $3.79 and a one year high of $7.66. The business has a fifty day moving average of $6.67 and a 200 day moving average of $6.53.

NeueHealth (NYSE:NEUEGet Free Report) last announced its earnings results on Thursday, May 8th. The company reported ($1.80) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.51) by $0.71. NeueHealth had a negative net margin of 36.28% and a negative return on equity of 6.40%. The company had revenue of $215.79 million during the quarter, compared to analyst estimates of $249.50 million. Analysts expect that NeueHealth, Inc. will post -9.13 EPS for the current fiscal year.

Insider Activity at NeueHealth

In other NeueHealth news, CFO Jay Matushak sold 4,448 shares of the company’s stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $6.74, for a total value of $29,979.52. Following the completion of the transaction, the chief financial officer now directly owns 41,592 shares in the company, valued at $280,330.08. This represents a 9.66% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO George Lawrence Mikan III sold 13,180 shares of the stock in a transaction that occurred on Wednesday, March 12th. The shares were sold at an average price of $6.93, for a total transaction of $91,337.40. Following the sale, the chief executive officer now directly owns 297,790 shares of the company’s stock, valued at approximately $2,063,684.70. This trade represents a 4.24% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 68,762 shares of company stock worth $471,711. 63.30% of the stock is owned by company insiders.

About NeueHealth

(Free Report)

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.

Featured Stories

Institutional Ownership by Quarter for NeueHealth (NYSE:NEUE)

Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.